NOV INC (NOV)

US62955J1034 - Common Stock

18.83  -0.03 (-0.16%)

After market: 18.83 0 (0%)

Fundamental Rating

5

Overall NOV gets a fundamental rating of 5 out of 10. We evaluated NOV against 65 industry peers in the Energy Equipment & Services industry. Both the profitability and the financial health of NOV get a neutral evaluation. Nothing too spectacular is happening here. NOV has a decent growth rate and is not valued too expensively.



4

1. Profitability

1.1 Basic Checks

NOV had positive earnings in the past year.
NOV had a positive operating cash flow in the past year.
In multiple years NOV reported negative net income over the last 5 years.
Of the past 5 years NOV 4 years had a positive operating cash flow.

1.2 Ratios

With an excellent Return On Assets value of 8.79%, NOV belongs to the best of the industry, outperforming 81.54% of the companies in the same industry.
With a decent Return On Equity value of 16.10%, NOV is doing good in the industry, outperforming 70.77% of the companies in the same industry.
The Return On Invested Capital of NOV (4.79%) is worse than 63.08% of its industry peers.
Industry RankSector Rank
ROA 8.79%
ROE 16.1%
ROIC 4.79%
ROA(3y)2.57%
ROA(5y)-12.85%
ROE(3y)4.71%
ROE(5y)-22.6%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin of NOV (11.57%) is better than 80.00% of its industry peers.
NOV has a Operating Margin (7.58%) which is in line with its industry peers.
NOV's Operating Margin has improved in the last couple of years.
NOV's Gross Margin of 21.36% is on the low side compared to the rest of the industry. NOV is outperformed by 63.08% of its industry peers.
NOV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.58%
PM (TTM) 11.57%
GM 21.36%
OM growth 3YN/A
OM growth 5Y24.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.17%
GM growth 5Y4.57%

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NOV is destroying value.
NOV has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NOV has more shares outstanding
NOV has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.04 indicates that NOV is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of NOV (2.04) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.31 indicates that NOV is not too dependend on debt financing.
NOV has a Debt to Equity ratio (0.31) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 2.04
ROIC/WACC0.61
WACC7.91%

2.3 Liquidity

A Current Ratio of 2.40 indicates that NOV has no problem at all paying its short term obligations.
NOV has a Current ratio of 2.40. This is in the better half of the industry: NOV outperforms 69.23% of its industry peers.
A Quick Ratio of 1.51 indicates that NOV should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.51, NOV perfoms like the industry average, outperforming 50.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.4
Quick Ratio 1.51

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 132.73% over the past year.
Measured over the past years, NOV shows a very strong growth in Earnings Per Share. The EPS has been growing by 62.19% on average per year.
NOV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.60%.
Measured over the past years, NOV shows a small growth in Revenue. The Revenue has been growing by 0.31% on average per year.
EPS 1Y (TTM)132.73%
EPS 3Y62.19%
EPS 5YN/A
EPS growth Q2Q7.69%
Revenue 1Y (TTM)18.6%
Revenue growth 3Y12.12%
Revenue growth 5Y0.31%
Revenue growth Q2Q13.02%

3.2 Future

Based on estimates for the next years, NOV will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.34% on average per year.
Based on estimates for the next years, NOV will show a small growth in Revenue. The Revenue will grow by 5.99% on average per year.
EPS Next Y19.11%
EPS Next 2Y20.35%
EPS Next 3Y19.77%
EPS Next 5Y13.34%
Revenue Next Year7.42%
Revenue Next 2Y6.9%
Revenue Next 3Y6.1%
Revenue Next 5Y5.99%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

NOV is valuated correctly with a Price/Earnings ratio of 14.71.
Based on the Price/Earnings ratio, NOV is valued a bit cheaper than 67.69% of the companies in the same industry.
When comparing the Price/Earnings ratio of NOV to the average of the S&P500 Index (25.25), we can say NOV is valued slightly cheaper.
NOV is valuated correctly with a Price/Forward Earnings ratio of 12.35.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NOV indicates a somewhat cheap valuation: NOV is cheaper than 63.08% of the companies listed in the same industry.
NOV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.67.
Industry RankSector Rank
PE 14.71
Fwd PE 12.35

4.2 Price Multiples

NOV's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.02

4.3 Compensation for Growth

NOV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NOV's earnings are expected to grow with 19.77% in the coming years.
PEG (NY)0.77
PEG (5Y)N/A
EPS Next 2Y20.35%
EPS Next 3Y19.77%

5

5. Dividend

5.1 Amount

NOV has a Yearly Dividend Yield of 1.08%.
Compared to an average industry Dividend Yield of 3.28, NOV pays a bit more dividend than its industry peers.
With a Dividend Yield of 1.08, NOV pays less dividend than the S&P500 average, which is at 2.45.
Industry RankSector Rank
Dividend Yield 1.08%

5.2 History

The dividend of NOV has a limited annual growth rate of 0.16%.
NOV has been paying a dividend for at least 10 years, so it has a reliable track record.
NOV has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.16%
Div Incr Years0
Div Non Decr Years3

5.3 Sustainability

NOV pays out 7.96% of its income as dividend. This is a sustainable payout ratio.
NOV's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP7.96%
EPS Next 2Y20.35%
EPS Next 3Y19.77%

NOV INC

NYSE:NOV (4/24/2024, 7:19:34 PM)

After market: 18.83 0 (0%)

18.83

-0.03 (-0.16%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap7.45B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.08%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 14.71
Fwd PE 12.35
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.77
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.79%
ROE 16.1%
ROCE
ROIC
ROICexc
ROICexgc
OM 7.58%
PM (TTM) 11.57%
GM 21.36%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.4
Quick Ratio 1.51
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)132.73%
EPS 3Y62.19%
EPS 5Y
EPS growth Q2Q
EPS Next Y19.11%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)18.6%
Revenue growth 3Y12.12%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y